<DOC>
	<DOCNO>NCT02222623</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness two different basal insulins commonly use basal blood sugar control treatment type 2 diabetes mellitus patient hospitalize require low dos insulin : neutral protamine Hagedorn ( NPH ) insulin glargine ( Lantus® ) insulin . Previous research show NPH insulin glargine ( Lantus® ) insulin safe effective control blood sugar type 2 diabetic patient . This research do cost medication diabetic patient expensive . Our goal research show less expensive insulin ( NPH ) safe effective expensive insulin [ glargine ( Lantus® ) ] patient type 2 diabetes mellitus hospital .</brief_summary>
	<brief_title>The Inova Type 2 Diabetes Mellitus Study</brief_title>
	<detailed_description>This randomize , open label trial compare effectiveness insulin glargine insulin NPH basal plus correctional regimen . Patients randomize either intervention ( NPH ) control group ( glargine ) upon admission . The following data collect : age , sex , weight , preadmission diabetes medication , admission diagnosis , HbA1C , blood glucose ( BG ) , chemistry , hematology , urine analysis , pregnancy test , duration hospitalization , insulin dose , discharge status . Data record maintain confidentially .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . Adult patient ages1875 admit general medicine surgical Department Medicine hospitalist service . 2 . A known history T2DM , receive either diet alone , low dose insulin ( ≤0.4 units/kg/day ) , OADs , GLP1 analog , combination OADs , GLP1 analogs low dose insulin ( ≤0.4 units/kg/day ) . 3 . Subjects must BG &gt; 140 mg/dL ≤240 mg/dL randomization without laboratory evidence diabetic ketoacidosis hyperglycemic hyperosmolar nonketotic syndrome ( bicarbonate &lt; 18 mEq/L , pH &lt; 7.30 , positive serum urinary ketone , BG &gt; 240 mg/dL ) . 1 . Patients diagnosis type 1 diabetes mellitus . 2 . Patients use nutritional bolus insulin home . 3 . Patients increase blood glucose concentration , without know history diabetes . 4 . Patients history diabetic ketoacidosis , hyperglycemic hyperosmolar nonketotic syndrome , ketonuria . 5 . Patients admit expected require admission intensive care unit ( ICU ) intermediate care unit ( IMC ) . 6 . Patients receive anticipated receive enteral parenteral nutrition . 7 . Patients admit cardiac surgery . 8 . Patients receive continuous insulin infusion . 9 . Patients clinically relevant hepatic disease ( diagnose liver cirrhosis portal hypertension ) , corticosteroid therapy , impaired renal function ( creatinine ≥ 3.5 mg/dL ) . 10 . Persons decisional incapacity ( mental condition render subject unable understand nature , scope , possible consequence study ) . 11 . Female subject pregnant immediately ( hospitalization ) post partum time enrollment study . 12 . Patients recognize suspected endocrine disorder associate increased insulin resistance , acromegaly , hyperthyroidism .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>insulin</keyword>
	<keyword>basal</keyword>
	<keyword>diabetes</keyword>
	<keyword>hospital</keyword>
	<keyword>glucose</keyword>
	<keyword>hypoglycemia</keyword>
	<keyword>glargine</keyword>
	<keyword>NPH</keyword>
	<keyword>neutral protamine hagedorn</keyword>
</DOC>